Last reviewed · How we verify
NCT06573450
Exhaled Breath Condensate Biomarkers in CARAS
trial testing questionnaire survey in Combined Allergic Rhinitis and Asthma Syndrome in 270 participants. Currently enrolling.
30 May 2025
Quick facts
| Lead sponsor | Henan University of Traditional Chinese Medicine |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 270 |
| Start date | 1 April 2023 |
| Primary completion | 30 May 2025 |
| Estimated completion | 30 May 2025 |
| Sites | 1 location across China |
Drugs / interventions tested
- questionnaire survey
Conditions studied
- Combined Allergic Rhinitis and Asthma Syndrome — all drugs for Combined Allergic Rhinitis and Asthma Syndrome →
Sponsor
Henan University of Traditional Chinese Medicine
Who can join
Adults 18 to 80, any sex, with Combined Allergic Rhinitis and Asthma Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To explore the differences in the expression of biomarkers in different sample types between the healthy population and different subgroups of the disease, and to screen for potential biomarkers in a more simple, direct and objective way. To screen the biomarkers that can be identified by CARAS Chinese medicine symptoms and different stages, and to provide a reference basis for individualised diagnosis and treatment of the disease.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06573450
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of questionnaire survey
Trials testing the same drug.
- NCT07335744 — Construction of a Multidimensional Risk Prediction Model for Severe Early Childhood Caries · not yet recruiting
- NCT06350305 — Screening for High-risk Chronic Obstructive Pulmonary Disease · not yet recruiting
- NCT06006234 — Analysis of Anxiety and Depression Among Elderly People · unknown
- NCT05461924 — The Long Term Outcomes After Pull-through of Long Segment Hirschsprung Disease · unknown
- NCT05443217 — Relationship Between Microbiota and Prognosis of Hepatocellular Carcinoma(HCC) After Systemic Treatments · unknown
Other Henan University of Traditional Chinese Medicine trials
Trials by the same sponsor.
- NCT07352488 — Modified Shenling Baizhu Powder for Allergic Asthma With Spleen Deficiency and Dampness Accumulation Syndrome · NA · not yet recruiting
- NCT07206745 — A Study on Integrated Chinese and Western Medicine for Severe Pneumonia Caused by Multidrug-Resistant Gram-Negative Bact · NA · not yet recruiting
- NCT07178392 — Disease-syndrome Characteristics of IPF · not yet recruiting
- NCT07162870 — Idiopathic Pulmonary Fibrosis Cohort of TCM · not yet recruiting
- NCT06914713 — Jin-shui Huan-xian Formula for Retarding the Decline of Pulmonary Function in IPF · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06573450 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Henan University of Traditional Chinese Medicine
- Last refreshed: 28 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06573450.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing